Skip to main content
. 2022 Jul 29;13(18):2584–2591. doi: 10.1111/1759-7714.14594

FIGURE 2.

FIGURE 2

Overall survival in patients with stage IV adenocarcinoma (a), epidermal growth factor receptor mutated stage IV adenocarcinoma (b), and anaplastic lymphoma kinase aberrated stage IV adenocarcinoma (c) according to sex.